We are creating some awesome events for you. Kindly bear with us.

Indian Government Plans to Assist Manufacturing Firms with Pharmaceutical Technology Fund

Indian Government Plans to Assist Manufacturing Firms with Pharmaceutical Technology Fund
[social-share align="left" style="icon" size="m" template="18" counters="0" total_counter_pos="leftbig" buttons="linkedin,twitter,facebook,share"]

India’s Department of Pharmaceuticals is working to establish a venture capital fund to offer affordable loans to small and marginal companies planning to set up new units in the pharmaceutical sector.

This will encourage pharmaceutical manufacturing companies to upgrade their production processes to match global standards. The fund is worth Rp500 crores (US$ 74. 95 million) which will support these facilities in terms of loans and subsidies.

This can prove to be a massive boost for the Indian populace as it can drive down the prices of medicine, making healthcare more affordable.

A senior government official associated this plan to India’s ‘’Make In India’’ initiative. ‘’ Make in India’’ is a government initiative launched in late 2014 by the Ministry of Finance in order to encourage multinational and domestic companies to manufacture their products in India.

"Following the Make in India theme we want to boost our domestic output in the pharma sector. It is felt that there is a need to provide loans or subsidies to the companies for upgrading their technologies as per global standards," said the official.

In addition to financial support, the government is also working on setting up parks for pharma products and medical device parks. It is also planning to increase generic medical outlet stores across India to 3000.

This plan will also facilitate research which can enable the discovery of new drugs. As a nation well equipped with capable scientists and engineers, Indian’s high potential in medicinal research can be expressed when investments in its R & D is in place.

Former advisor of India’s Department of Science and Technology, GJ Samanatham, echoes the sentiment of India’s potential.

"India has a great role to play in novel drug discovery. Our scientists must take up high-risk and high resource-oriented long-term research." he said.

The government is proposing to partner the National Institute of Pharmaceutical Education and Research with private firms to facilitate drug discovery . Such institutions are expected to rise over the next five years.

Image from Shashank MhasawadeCC BY 2.0

[easy-social-share align="center" style="button" size="xxl" template="59" counters=0 noaffiliate="no" sidebar="no" popup="no" float="no" postfloat="no" topbar="no" bottombar="no" point="no" mobilebar="no" mobilebuttons="no" mobilepoint="no" facebook_text="Share on Facebook" linkedin_text="Share on LinkedIn" buttons="linkedin,facebook"]

PARTNER

Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.

PARTNER

CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.

PARTNER

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.

SUPPORTING ORGANISATION

SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.

PARTNER

HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 

PARTNER

IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.